Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Non-Current Assets (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Other Non-Current Assets for 11 consecutive years, with $16000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 70.91% year-over-year to $16000.0, compared with a TTM value of $16000.0 through Dec 2025, down 70.91%, and an annual FY2025 reading of $16000.0, down 70.91% over the prior year.
  • Other Non-Current Assets was $16000.0 for Q4 2025 at Wave Life Sciences, down from $22000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.7 million in Q1 2023 and bottomed at $16000.0 in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $2.4 million, with a median of $3.7 million recorded in 2021.
  • The sharpest move saw Other Non-Current Assets surged 2507.86% in 2021, then crashed 98.51% in 2024.
  • Year by year, Other Non-Current Assets stood at $148000.0 in 2021, then soared by 2400.0% to $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then plummeted by 98.51% to $55000.0 in 2024, then tumbled by 70.91% to $16000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for WVE at $16000.0 in Q4 2025, $22000.0 in Q3 2025, and $3.8 million in Q2 2025.